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ABSTRACT 
Objective: Simple, sensitive, precise, reproducible and validated visible spectrophotometric methods have been developed for the determination of 
an angiotensin converting enzyme inhibitor (ACE) drug, namely enalapril maleate (ENP) in pure and pharmaceutical dosage forms.  
Methods: The methods are based on the formation of yellow colored ion-pair complexes between enalapril with two sulphonphthalein acid dyes, 
bromocresol purple (BCP) and bromophenol blue (BPB) at pH 2.8 and 3.0 using BCP and BPB, respectively followed by their extraction with 
chloroform. Several parameters such as pH, buffer type, reagent volume, sequence of addition and effect of extracting solvent were optimized to 
achieve high sensitivity, stability, low blank reading and reproducible results. 
Results: The absorbance is measured at 408 and 414 nm using BCP and BPB reagents, respectively. The stoichiometric ratio of the formed ion-pair 
complexes was found to be 1:1 (drug: reagent) for both methods as deduced by Job's method of continuous variation. Under the optimum reaction 
conditions, linear relationships with good correlation coefficients (0.9993-0.9996) were found between the absorbance's and the concentrations of 
enalapril over the concentration ranges of 2.0–24 μg ml-1 and 2.0–28 μg ml-1 with limits of detection (LOD) of 0.39 and 0.45 μg ml-1, using BCP and 
BPB methods, respectively. Various analytical parameters have been evaluated and the results have been validated by statistical data.  
Conclusion: The proposed methods were validated in accordance with ICH guidelines and successfully applied to the determination of enalapril in 
pure and Dosage forms. Statistical comparison of the results obtained by applying the proposed methods with those of the official method revealed 
good agreement and proved that there were no significant difference in the accuracy and precision between the results.  
Keywords: Enalapril maleate, Ion-pair complex, Bromocresol purple, Bromophenol blue, Spectrophotometry, Dosage forms. 
 
INTRODUCTION 
Enalapril maleate (ENP); (S)-1-[N-[1-(ethoxycarbonyl)-3-phenyl 
propyl]-L-alanyl]-L-proline hydrogen maleate belong to the class of 
a dicarboxylate containing group of angiotensin converting enzyme 
inhibitors (ACEIs) (fig. 1). Enalapril malate is widely used in the 
treatment of hypertension and some types of chronic heart failures 
[1, 2]. The official methods of analysis of ENP in pharmaceuticals are 
high-performance liquid chromatography (HPLC) in USP [1] and 
British Pharmacopoeia (BP) [2]. The analytical profiles of the drug 













Fig. 1: Chemical structure of enalapril maleate (ENP) 
 
A review of the literature revealed that several methods have been 
reported for the quantitative determination of ENP both in 
pharmaceutical preparations and in biological fluids, including high-
performance liquid chromatography (HPLC) methods [4-14], 
potentiometric methods [15, 16], chemiluminescence method [17] 
and nuclear magnetic resonance spectroscopy (1H-NMR) [18]. 
Most of the reporting procedures are not simple for routine analysis 
and require expensive or sophisticated instruments. Hence, it is always 
required to develop simple, fast, inexpensive analytical methods that 
can be readily adopted for routine analysis at a relatively low-cost to 
the different requirements of analytical problems.  
Visible spectrophotometry, because of its simplicity and cost 
effectiveness, sensitivity and selectivity, fair accuracy, precision and 
easy access in most quality control laboratories, has remained 
competitive in an area of chromatography techniques for 
pharmaceutical analysis. Ultraviolet [19-21] and visible [22-37] 
spectrophotometric methods have been reported for the 
determination of ENP in pharmaceuticals. However, most of the 
reported visible spectrophotometric methods [22-37] suffer from 
one or the other disadvantage like the narrow range of 
determination, poor sensitivity, the use of heating, strict pH control, 
indirect method etc. as shown in table 1.  
Ion pair extractive spectrophotometric procedures are popular for 
their sensitivity in the assay of drugs[38− 46]. In the present work, 
two simple, accurate, sensitive, low-cost and validated extractive 
spectrophotometric methods based on ion-pair formation reaction 
between ENP and an anionic dyes such as bromocresol purple 
(BCP) and bromophenol blue (BPB) are proposed for the 
determination of ENP in pure form and pharmaceutical 
preparations. 
MATERIALS AND METHODS 
Apparatus 
All absorption spectra were made using Kontron Unikon 930 (UV-
Visible) spectrophotometer (German) with a scanning speed of 200 
nm/min and a band width of 2.0 nm, equipped with 10 mm matched 
quartz cells. The pH values of different buffer solutions were 
checked using a Hanna pH-meter instrument (pH 211) (Romania) 
equipped with a combined glass-calomel electrode. 
Materials and reagents  
All chemicals and reagents were of analytical grade and used 
without further purification and all solutions were prepared fresh 
daily. Water has been always doubly distilled. 
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Potassium permanganate in neutral medium 340 2.0-12 1.8 x 104 0.028 [23] 
Potassium permanganate in H2SO4 medium 550 7.0-70 3.8 x 103 0.115 
Potassium permanganate in acidic medium/     [24] 
Acid red 73 (AR) 510 0.7-12, 4.96 x 104 0.197 
Amaranth dye [acid red 27] (AM) 521 0.5-7.6 6.49 x 104 0.138 
Acid orange 7 (AO) 484 0.6-9.5 5.09 x 104 0.147 
Bromothymol blue (BTB) 404 10-48  0.40 [25] 
Molybdenum (V)-thiocyanate 468 10-80  0.18 
Molybdenum(V) thiocyanate 517 4.0-36 3.4×104  [26] 
Molybdenum(V) thiocyanate/benzalkonium chloride 545 3.0-27 5.0×104  
Potassium iodate (KIO3)/(KI) 352 2.5-50  1.13 [27] 
p-chloranilic acid (pCA) in 1, 4-dioxan-methanol medium, 510 20-560  3.07 
2, 3-dichloro 5, 6-dicyano 1, 4-benzoquinone (DDQ) in 
acetonitrile-1,4 dioxane medium 
565 5.0-75  0.39 
Iodine 365 10-200  3.20 
Methyl orange 425 4.0-20   [28]. 
Palladium(II) chloride 362.8 50-300 1.3×103  [30] 
Palladium(II), eosin/methylcellulose 550.6 8.0-56 2.7×104  
Copper(II), eosin 533.4 56-112   [31] 
Copper(II), eosin/methylcellulose 558.8 19-32   
Iron(III), thiocyanate 436.6 60-132   
Bromothymol blue 410 10–160 3.414x103  [32] 
FeCl3/Potassium Ferricyanide  778 10–60 3.656x104  
FeCl3/2, 2’–Bipyridyl 520 10-60 2.811x103  
Tropeolin 00/HCl 415 10-100 5.206 x 103 2.03 [33] 
Potassium dichromate (0.1N)/50 % H2SO4  574 5–60  0.99 [34] 
Potassium dichromate  610 25-900  7.59 [35] 
Potassium permanganate 520 10-200  2.4 
Cu(II)/Bromothymol blue 426 200-500 - 9.907 [36] 
Bromocresol purple (BCP) 408 2.0-24 7.714 x 103 0.39 Proposed 
work Bromophenol blue (BPB) 414 2.0-28 7.325 x 103 0.45 
 
Materials 
Standard ENP was obtained from Egyptian International of 
Pharmaceutical Industries Company (EIPICO), 10th of Ramadan City, 
Egypt.  
Pharmaceutical formulations 
All pharmaceutical preparations were obtained from commercial 
sources in the local markets.  
- Acapril tablets labeled to contain (20 mg ENP/tablet) were 
purchased from Alpha Chem Advanced Pharmaceutical Industries 
Company (ACAPI), Bader Industrial City, Cairo, Egypt.  
- Ezapril tablets labeled to contain (10 mg ENP/tablet) were 
purchased from El-Kahira Pharmaceutical and Chemical Industries 
Company, Cairo, Egypt.  
- Enalapril tablets labeled to contain (20 mg ENP/tablet) were 
purchased from Egyptian International of Pharmaceutical Industries 
Company (EIPICO), 10th of Ramadan City, Egypt.  
Preparation of stock standard solution 
A stock standard ENP solution (100 µg ml-1) and (1.0 × 10−3 mol l-1) 
were prepared by dissolving an exact weight 10 and 49 mg of pure 
drug in bidistilled water and adjusted to 100 ml with bidistilled 
water in 100 ml measuring flask. The standard solutions were found 
stable for at least one week without alteration when kept in an 
amber colored bottle and stored in a refrigerator when not in use. 
Serial dilution with the same solvent was performed to obtain the 
appropriate concentration range. 
Reagents 
All reagents and solvents used were of analytical-reagent grade. 
Bromocresol purple (BCP) and bromophenol blue (BPB) (BDH 
Chemicals LTD, Poole, England) and used without further 
purification. Stock solutions (1.0×10−3 mol l-1) of reagents were 
prepared by dissolving the appropriate weight of each reagent in 5.0 
ml of 96% ethanol and diluted to 100 ml in a calibrated flask with 
bid stilled water. These solutions were stable for at least one week if 
kept in the refrigerator.  
Series of buffer solutions of NaOAc–HCl (pH=1.99-4.92), NaOAc–
AcOH (pH=3.4-5.6) and potassium hydrogen phthalate–HCl (pH=2.0-
7.0) were prepared by following the standard methods [47]. The pH 
of each solution was adjusted to an appropriate value by the 
addition of 0.2 mol l-1 hydrochloric acid or sodium hydroxide with 
the help of the pH meter. Freshly prepared solutions were always 
employed. Chloroform and dichloromethane (BDH), anhydrous 
sodium sulfate (Prolabo), ethanol (BDH). 
General procedures 
Accurately measured aliquots (0.2–2.8 ml) of the standard ENP 
solution (100 µg ml-1) were transferred to 10 ml measuring flasks. A 
volume 2.0 ml acetate buffer of pH 2.8 and 3.0 using BCP and BPB, 
respectively was added. Then add 2.5 ml of 1.0 × 10-3 mol l-1 BCP or 
BPB reagent solution. The total volume of each solution was 
completed to 10 ml with bidistilled water. The formed ion associate 
complexes were extracted with 10 ml chloroform by shaking for 
2.0 min, then allowed to stand for clear separation of the two phases 
and the chloroform layer was passed through anhydrous sodium 
sulfate. The absorbance of the yellow colored ion-pair complexes 
were measured at 408 and 414 nm using BCP and BPB, respectively 
against corresponding reagent blank similarly prepared. All 
measurements were made at room temperature (25±2 °C). In both 
methods, a standard curve was prepared by plotting the absorbance 
values versus concentrations of drug. A linear equation for the 
standard curve was calculated by linear regression. 
Applications to pharmaceutical formulations 
The contents of twenty tablets were crushed, finely powdered, 
weight out and the average weight of one tablet was determined for 
each drug. An accurate weight equivalent to 10 mg ENP was 
transferred into a 100 ml calibrated flask, dissolved in bidistilled 
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water with shaking for 5.0 min and filtered through a sintered glass 
crucible (G4). The filtrate was diluted to 100 ml with bidistilled 
water in a 100 ml measuring flask to give 100 μg ml-1stock solutions. 
Aliquot of the cited solutions was taken and analyzed as described 
under the above recommended procedures for construction of 
calibration curves. For the proposed methods, the content of tablets 
was calculated using the corresponding regression equation of the 
appropriate calibration graph. The method of standard addition was 
used for the accurate determination of ENP content. 
Stoichiometric relationship  
The stoichiometric ratios of the ion-associates formed between ENP 
and the reagents were determined by applying the continuous 
variation [48] and the molar ratio [49] methods at the optimum 
wavelengths of maximum absorbance. In continuous variation 
method, an equimolar solution was employed: a 1.0 x 10-3 mol l-1 
standard solution of ENP and 1.0 x 10-3 mol l-1 solution of dye was 
used. A series of solutions was prepared in which the total volume of 
ENP and the dye was kept at 2.0 ml. The drug and reagent were mixed 
in various complementary proportions (0.2:1.8, 0.4:1.6, 0.6:1.4, 0.8:1.2, 
1.0:1.0, 1.2:0.8, 1.4:0.6, 1.6:0.4, 1.8:0.2) and completed to volume in a 
10 ml calibrated flask with the appropriate solvent for extraction 
following the above mentioned procedure. In the molar ratio method, 
the concentrations of ENP are kept constant to 1.0 ml of (1.0 x10-3 mol 
l-1) while that of dye (1.0 x10-3 mol l-1) is regularly varied (0.2–2.4 ml). 
The absorbance of the prepared solutions was measured at the 
optimum wavelength for each complex. 
RESULTS  
Absorption spectra 
The nitrogenous drugs are present in positively charged protonated 
forms and anionic dyes of sulphonpthalein group present mainly in 
anionic form at a pH ≥ 2.5. So when treated with an acid dye at a pH 
range (2.5-5.0) of acidic buffer solutions, a yellow ion-pair complex 
which is extracted with chloroform is formed. The absorption spectra 
of the ion-pair complexes, which were formed between ENP and (BCP 
or BPB) reagents were measured in the range 350–550 nm against the 
blank solution. The maximum absorbance's of ion-pair complexes 
show at 408 and 414 nm using BCP and BPB, respectively (fig. 2). 
 
 
Fig. 2: Absorption spectrum of ion-pair complexes of ENP and 
(1.0 x 10-3 mol l-1) BCP and BPB reagents against reagent blank 
 
Optimum reaction conditions for complex formation 
The optimization of the methods was carefully studied to achieve the 
complete reaction formation, highest sensitivity and maximum 
absorbance. Reaction conditions of the ion-pair complex were found 
by studying with preliminary experiments such as pH of buffer, the 
type of organic solvent, volumes of the dye, reaction time and 
temperature for the extraction of ion-pair complexes.  
Effects of pH on ion-pair formation 
The effect of pH on the drug–reagent complex formation was studied 
by extracting the colored complexes in the presence of various 
buffers such as NaOAc–HCl (pH 1.99-4.92) and NaOAc–AcOH (pH 
3.6-5.6). It was noticed that the maximum color intensity and highest 
absorbance value were observed in NaOAc-HCl buffer of pH 2.8 and 
3.0 for BCP and BPB method, respectively (fig. 3). Buffer volume was 
determined by applying the same experiment and variation the 
volume regularly (0.5-4.0 ml). The higher absorbance value and 






















Fig. 3: Effect of pH of buffer solution on ion pair complex 
formation between (24 μg ml-1) ENP and (1.0 x 10-3 mol l-1) BCP 
and BPB reagents 
 
Effects of reagent concentration 
The effect of the reagent was studied by measuring the absorbance's 
of solutions containing a fixed concentration of ENP and varied 
amounts of the respective reagents 1.0×10-3 mol l-1 (BCP or BPB) 
from 0.5–4.0 ml. The maximum color intensity of the complex was 
achieved with 2.5 ml of (1.0 × 10−3 M) (BCP or BPB) reagent 
solutions. After this volume, the absorbance remains constant by 
increasing the volume of the reagents (fig. 4). So an excess of 
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Fig. 4: Effect of volume of (1.0 ×10−3 mol l-1) BCP and BPB reagent 
on the ion pair complex formation with (24 μg ml-1) ENP 
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Effect of extracting solvent 
Different organic solvents as dichloromethane, carbon tetrachloride, 
chloroform and ether were tested as extractive solvents for the 
proposed methods. Chloroform was preferred to other solvents for 
its selective and obtained the highest absorbance with chloroform. It 
was also observed that only one extraction with total volume 10 ml 
solvent was adequate to achieve a quantitative recovery of the 
complexes, maximum absorbance intensity and considerably lower 
extraction ability for the reagent blank and the shortest time to 
reach the equilibrium between both phases. 
Effect of shaking time and temperature 
The optimum shaking time was investigated by shaking from 0.5-
5.0 min. Maximum and constant absorbance value was obtained 
when extracted after 1.5 min shaking. Therefore, shaking time of 2.0 
min was maintained throughout the experiment. The effect of 
temperature on colored complexes was studied by measuring the 
absorbance values over the temperature range 20-35 °C. It was 
found that the absorbance of the colored ion pair complex was 
constantly up to 30 °C. At higher temperatures, the drug 
concentration was found to increase due to the volatile nature of the 
chloroform. Therefore, the temperature chosen was room 
temperature (25±2 °C) as the best temperature for micro-
determination of ENP in pure and dosage forms. The absorbance of 
both complexes remains stable for at least 12 h at room 
temperature. 
Stoichiometric relationship 
The molar ratio between ENP and BCP or BPB in the ion-pair 
complexes was determined by Job’s method of continuous variation 
[48]. Continuous variation method of equimolar solutions was 
employed: a 1.0 × 10−3 mol l-1 standard solution of drug base and 
1.0 × 10−3 mol l-1 solution of BCP or BPB were used. A series solution 
was prepared in which the total volume of drug and reagent was 
kept at 2.0 ml in the total volume of 10 ml of the aqueous layer. The 
absorbance of extracting ion-pair in each instance was measured at 
the optimum wavelength and plotted against the mole fraction of the 
drug. The results indicate that the molar ratio of (drug: dye) is (1:1) 
complex was formed through the electrostatic attraction between 
the positive charged ENP+ions and negatively charged BCP− and BPB-
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Fig. 5: Job’s method of continuous variation graph for the 
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Scheme 1: Proposed reaction mechanism for the ion pair complex formation between ENP and BCP 
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Method of validation 
Linearity 
At described experimental conditions for ENP determination, 
standard calibration curves with reagents were constructed by 
plotting absorbance vs. concentration of ENP. The statistical 
parameters were given in the regression equation calculated from 
the calibration graphs A = aC+b, where A is the absorbance and C is 
concentration in μg ml-1. The linearity of calibration graphs was 
proved by the high values of the correlation coefficient (r) and the 
small values of the y-intercepts of the regression equations. The 
apparent molar absorptivity of the resulting colored ion-pair 
complexes and relative standard deviation of response factors for 
each proposed spectrophotometric method were also calculated and 
recorded in table 2. The molar absorptivity of BCP>BPB ion-pair 
complexes with ENP. 
Sensitivity 
The limits of detection (LOD) and quantitation (LOQ) for the 
proposed methods were calculated using the following equation [50, 
51]:  
LOD = 3s/k and LOQ = 10 s/k 
Where s is the standard deviation of the response of the blank or the 
standard deviation of intercepts of regression lines and k is the 
sensitivity, namely the slope of the calibration graph. In accordance 
with the formula, the limit of detection was found to be 0.39 and 
0.45 µg ml−1 for BCP and BPB methods, respectively. The limit of 
quantitations was found to be 1.30 and 1.50 µg ml−1 using BCP and 
BPB methods, respectively (table 2).  
Accuracy and precision  
In order to evaluate the accuracy and precision of the proposed 
methods, solutions containing three different concentrations of ENP 
were prepared and The assay procedure was analyzed in six 
replicates, and percentage relative standard deviation (% R. S. D) 
values were obtained within the same day to evaluate repeatability 
(intra-day precision) and over five different days to evaluate 
intermediate precision (inter-day precision). The analytical results 
of intra-day and inter-day precision and accuracy were summarized 
in table 3. The low values of percentage relative standard deviation 
(R. S. D %) as precision and percentage relative error (RE %) as 
accuracy of the proposed methods were calculated. The percentage 
relative error was calculated using the following equation:  
RE % = [(founded–added)/added] x 100 
These results of accuracy and precision show that the proposed 
methods have good repeatability and reproducibility 
 
Table 2: Statistical analysis of calibration graphs and analytical 
data in the determination of ENP using the proposed methods 
Parameters BCP BPB 
Wavelengths λ max (nm) 408 414 
Beer’s law limits (µg ml−1) 2.0-24 2.0-28 
Molar absorptivity ε, (l mol-1 cm-1) x 103 7.714 7.325 
Sandell,s sensitivity (ng cm-2) 50.89 53.59 
Regression equation a   
Intercept (a) 0.0002 -0.0006 
Slope (b) 0.0194 0.0189 
Correlation coefficient (r) 0.9996 0.9993 
LOD (µg ml−1)b 0.39 0.45 
LOQ (µg ml−1)b 1.30 1.50 
mean±SD 99.79±1.87 99.90±1.18 
RSD% 1.87 1.18 
RE% 1.96 1.24 
t-test c  0.66 0.75 
F-testc 4.31 1.72 
a A = a+bC, where C is the concentration in µg mL−1, A is the 
absorbance units. 
b LOD, limit of detection; LOQ, limit of quantification; ε,molar 
absorptivity. 
c The theoretical values of t and F at P= 0.05 are 2.571 and 5.05, 
respectively. 
 
Table 3: Intra-day and Inter-day precision and accuracy data for ENP obtained by the proposed methods 



















BCP 6.0 99.30 0.51 -0.70 5.958± 
0.032 
100.20 0.45 0.20 6.012± 
0.028 
 12 99.50 0.85 -0.50 11.94± 
0.107 
99.10 0.64 -0.90 11.892± 
0.08 
 24 100.20 1.40 0.20 
 
 
100.50 1.20 0.50 
 
BPB 6.0 99.00 0.60 -1.00 
 
 
99.50 0.36 -0.50 5.97± 
0.023 
 12 100.60 0.70 0.60 99.80 0.58 -0.20 11.976±0.073 
Gouda et al. 




 24 99.40 1.10 0.60 
 
 
100.70 0.95 0.70 24.168± 
0.241 
a Mean of six determination, RSD%, percentage relative standard deviation; RE%, percentage relative error. 
b Confidence limit at 95% confidence level and five degrees of freedom (t = 2.571). 
 
Robustness and ruggedness 
The robustness of the method was evaluated by making small 
incremental changes in volume of dye, pH and shaking time, and the 
effect of these changes on the absorbance of the colored systems was 
studied. The changes had negligible influence on the results as 
revealed by small intermediate precision values expressed as RSD (≤ 
3.0 %). Method ruggedness was demonstrated by having the 
analysis done by two analysts, and also by a single analyst 
performing analysis on two different instruments in the same 
laboratory. The results showed no statistical differences between 
different analysts and instruments, suggesting that the developed 
methods were robust and rugged. Intermediate precision values 
(RSD) of this study were ≤ 3.0 % indicating acceptable ruggedness.  
Effects of interference 
To assess the usefulness of the method, the effect of diluents, 
excipients and additives which often accompany ENP in its dosage 
forms (tablets) (starch, lactose, glucose, saccarose, talc, sodium 
chloride, titanium dioxide, and magnesium stearate) were studied. 
The results indicated that there is no interference from excipients 
and additives, indicating a high selectivity for determining the 
studied ENP in its dosage forms. 
Applications of pharmaceutical formulations 
The proposed methods have been successfully applied to the 
determination of ENP in dosage forms (Acapril tablets; Ezapril 
tablets and Enalapril tablets). Six replicates determinations were 
made. Moreover, to check the validity of the proposed methods, 
dosage forms were tested for possible interference with standard 
addition method (table 4). There was no significant difference 
between the slopes of calibration curves and standard addition 
method. Therefore, it is concluded that the excipients in 
pharmaceutical preparations of ENP did not cause any interference 
in the analysis of ENP. The results were compared with those 
obtained using the reported method for ENP [24]. Statistical analysis 
of the results did not detect any significant difference between the 
proposed methods and the reported method [24] in pharmaceutical 
formulations with respect to accuracy and precision as revealed by 
the Student’s t-value and variance ratio F-value at 95% confidence 
level [51]. The results show that the Student’s t-and F-values at 95 % 
confidence level did not exceed the theoretical values which 
confirmed that there is a good agreement between the results 
obtained by the proposed methods and the reported method [24] 
with respect to accuracy and precision (table 4). 
 
Table 4: Application of the standard addition technique for the determination of ENP in dosage forms using the proposed methods 
Sample Taken 
(μg ml-1) 
BCP BPB reported method [24] 
Added (μg ml-1) Recoverya (%) Added (μg ml-1) Recoverya (%) 
Acapril tablets 4.0 - 99.70 - 99.30  
  4.0 99.30 8.0 100.70  
  8.0 100.40 12 99.20  
  12 99.00 16 99.80  
  16 98.80 20 99.10  
mean±SD    99.44±0.635  99.62±0.661 99.30±0.60 
R. S. D%   0.631  0.658 0.596 
V   0.403  0.437 0.355 
S. E   0.284  0.296 0.267 
t-valueb   0.36  0.80  
F-valueb   1.12  1.21  
Ezapril tablets 4.0 - 99.60 - 100.05  
  4.0 100.30 8.0 99.70  
  8.0 99.80 12 100.00  
  12 99.10 16 99.50  
  16 100.10 20 99.00  
mean±SD    99.78±0.466  99.65±0.427 99.70±0.52 
R. S. D%   0.465  0.468 0.518 
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V   0.217  0.183 0.270 
S. E   0.208  0.191 0.233 
t-valueb   0.16  0.17  
F-valueb   1.25  1.48  
Enalapril tablets 4.0 - 99.80 - 99.20  
  4.0 99.50 8.0 98.70  
  8.0 99.40 12 100.40  
  12 98.90 16 99.60  
  16 100.10 20 99.50  
mean±SD    99.54±0.451  99.48±0.622 99.40±0.70 
R. S. D%   0.449  0.619 0.696 
V   0.203  0.387 0.49 
S. E   0.201  0.278 0.313 
t-valueb   0.38  0.19  
F-valueb   1.09  1.27  
aAverage of six determinations. 
b The theoretical values of t and F are 2.571 and 5.05, respectively at confidence limit at 95% confidence level and five degrees of freedom (p= 0.05). 
 
DISCUSSION 
The proposed methods are based on the reactivity of tertiary amine 
group of ENP with two acid dyes (BCP and BPB). ENP forms an ion-
association complex with acid dyes which is extractable into 
chloroform from the aqueous phase. The protonated nitrogen 
(positive charge) of ENP as hydrochloride is expected to attract the 
oppositely charged part (negative charge) of the dye in acidic buffer 
solution at pH ≥ 2.5 and behave as a single unit being held together 
by electrostatic attraction and a yellow ion-pair complex which is 
extracted with organic solvent is formed. The absorption spectra of 
the yellow ion-pair complexes, which were formed between ENP and 
BCP or BPB reagents and show maximum absorbance's at 409 and 
415 nm, respectively against the blank solution.  
The results indicate that the molar ratio of (drug: dye) is (1:1) 
complex was formed through the electrostatic attraction between 
the positive charged ENP+ions and negatively charged dye, D− ions. 
The extraction equilibrium can be represented as follows:  
 
Where, ENP+ and D− represent the protonated drug and the anion of 
the dye (BCP− or BPB−), respectively, and the subcript (aq) and (org) 
refer to the aqueous and organic phases, respectively.  
CONCLUSION 
This paper describes the application of extractive ion–pair 
complexation reaction with acid dyes for the quantification of ENP in 
pure and dosage forms. Compared with the existing 
spectrophotometric methods, the proposed methods are relatively 
simple, rapid, cost-effective, free from auxiliary reagents and more 
sensitive for determination of ENP in pure and dosage forms. 
Moreover, the proposed methods are free from tedious experimental 
steps such as heating unlike the previously reported methods. The 
most attractive feature of these methods is its relative freedom from 
interference by the usual diluents and excipients in amounts far in 
excess of their normal occurrence in pharmaceutical formulations. 
The statistical parameters and the recovery data reveal good 
accuracy and precision of the methods. Therefore, the validated 
methods could be useful for routine quality control assay of ENP in 
pure and dosage forms. 
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